Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Sorafenib × CNS × Clear all

Phase

Status

Completed 14 Terminated 2 Withdrawn 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 9 Other hematologic neoplasm 5 Head & Neck 4 Sarcoma 3 Tumor-Agnostic 1 Myeloid 1 Lymphoid 1 Endocrine 1 Dermatologic 1 CNS 1

Conditions

Recurrence 1 Neuroblastoma 1

Interventions

Temozolomide 55 Radiotherapy 32 Magnetic Resonance Spectroscopy 31 Radiosurgery 24 Specimen Handling 21 Cyclophosphamide 21 Nivolumab 20 pembrolizumab 17 Radiation 16 Carboplatin 12 Bevacizumab 12 Biopsy 11 Ipilimumab 10 Cisplatin 10 Vincristine 9 Irinotecan 9 trametinib 8 Immunoglobulin G 8 Etoposide 8 dinutuximab 7 X-Rays 7 Topotecan 7 Lomustine 7 Disulfides 7 AZD 6244 7 sargramostim 6 olaparib 6 atezolizumab 6 Granulocyte-Macrophage Colony-Stimulating Factor 6 CTLA-4 Antigen 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02298348 2025-02-17

N2013-02

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Active not recruiting

Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡